Gene: Psmb9 (proteasome 20S subunit beta 9) Rattus norvegicus
Analyze
Symbol:
Psmb9
Name:
proteasome 20S subunit beta 9
Description:
Exhibits proteasome binding activity. Involved in several processes, including cellular response to electrical stimulus; hematopoietic or lymphoid organ development; and response to benzene. Localizes to the cytosol and proteasome complex. Biomarker of breast carcinoma and peptic esophagitis. Human ortholog(s) of this gene implicated in ankylosing spondylitis; autoimmune hypersensitivity disease (multiple); lymphoma; psoriasis; and renal cell carcinoma. Orthologous to human PSMB9 (proteasome 20S subunit beta 9); PARTICIPATES IN ubiquitin/proteasome degradation pathway; INTERACTS WITH (+)-schisandrin B; 1,3-dinitrobenzene; 1-naphthyl isothiocyanate.
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
large multifunctional protease 2; Lmp2; low molecular mass polypeptide 2; low molecular mass protein 2; macropain chain 7; multicatalytic endopeptidase complex chain 7; proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2); proteasome (prosome, macropain) subunit, beta type, 9; proteasome chain 7; proteasome subunit beta 9; proteasome subunit beta type-9; proteasome subunit beta-1i; proteosome (prosome macropain) subunit beta type 9 (large multifunctional protease 2); proteosome (prosome, macropain) subunit, beta type 9; really interesting new gene 12 protein; RING12 protein
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PSMB9 (proteasome 20S subunit beta 9) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Psmb9 (proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)) HGNC
Treefam, NCBI, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Psmb9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PSMB9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PSMB9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Psmb9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PSMB9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
PSMB9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Psmb9 (proteasome 20S subunit beta 9) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Psmb9 (proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2))
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Homo sapiens (human):
PSMB9 (proteasome 20S subunit beta 9)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Danio rerio (zebrafish):
psmb9a (proteasome subunit beta 9a)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Danio rerio (zebrafish):
psmb9b (proteasome subunit beta 9b)
Alliance
DIOPT (Hieranoid, OrthoFinder, PhylomeDB)
Saccharomyces cerevisiae (baker's yeast):
PRE3
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Drosophila melanogaster (fruit fly):
Prosbeta1
Alliance
DIOPT (Ensembl Compara, OrthoFinder, PANTHER, PhylomeDB, TreeFam)
Caenorhabditis elegans (roundworm):
pbs-1
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 20 3,973,424 - 3,978,845 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 20 3,973,420 - 3,978,845 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 20 6,052,972 - 6,058,393 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 20 4,801,187 - 4,806,608 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 20 4,801,449 - 4,806,835 (+) NCBI Celera 20 6,268,113 - 6,273,528 (+) NCBI Celera Cytogenetic Map 20 p12 NCBI RH 3.4 Map 20 58.54 RGD
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
Imported Annotations - ClinVar
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3 ISO RGD:737219 8554872 ClinVar Annotator: match by term: PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3 ClinVar PMID:26524591
Imported Annotations - CTD
acrodermatitis ISO RGD:737219 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27258892 Experimental Liver Cirrhosis ISO RGD:737219 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:25380136 Imported Annotations - OMIM
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3 ISO RGD:737219 7240710 OMIM
(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PSMB9 mRNA] CTD PMID:31150632 1,3-dinitrobenzene affects expression EXP 6480464 3-dinitrobenzene affects the expression of PSMB9 mRNA CTD PMID:16988215 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PSMB9 mRNA CTD PMID:25380136 1-nitropyrene decreases expression ISO RGD:737219 6480464 1-nitropyrene results in decreased expression of PSMB9 mRNA CTD PMID:19041380 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PSMB9 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:737219 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PSMB9 mRNA, [Estradiol co-treated with TGFB1 protein] results in decreased expression of PSMB9 mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol increases expression ISO RGD:737219 6480464 Estradiol results in increased expression of PSMB9 mRNA CTD PMID:19619570 , PMID:21185374 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:11180 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737219 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PSMB9 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of PSMB9 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSMB9 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PSMB9 mRNA CTD PMID:15644576 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737219 6480464 Tetrachlorodibenzodioxin results in decreased expression of PSMB9 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11180 6480464 Tetrachlorodibenzodioxin results in increased expression of PSMB9 mRNA CTD PMID:19933214 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of PSMB9 mRNA CTD PMID:14600272 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PSMB9 mRNA CTD PMID:25380136 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of PSMB9 mRNA CTD PMID:21893156 4-hydroxyphenyl retinamide increases expression ISO RGD:11180 6480464 Fenretinide results in increased expression of PSMB9 mRNA CTD PMID:28973697 aflatoxin B1 affects expression ISO RGD:737219 6480464 Aflatoxin B1 affects the expression of PSMB9 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:737219 6480464 Aflatoxin B1 results in increased methylation of PSMB9 exon CTD PMID:30157460 Aflatoxin G1 decreases expression ISO RGD:737219 6480464 aflatoxin G1 results in decreased expression of PSMB9 protein CTD PMID:20381597 all-trans-retinoic acid increases expression ISO RGD:737219 6480464 Tretinoin results in increased expression of PSMB9 mRNA CTD PMID:15498508 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PSMB9 mRNA CTD PMID:16483693 antirheumatic drug multiple interactions ISO RGD:737219 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of PSMB9 mRNA CTD PMID:16817978 antirheumatic drug decreases expression ISO RGD:737219 6480464 Antirheumatic Agents results in decreased expression of PSMB9 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO RGD:11180 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of PSMB9 mRNA CTD PMID:23650126 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of PSMB9 gene CTD PMID:28931070 azathioprine decreases expression ISO RGD:737219 6480464 Azathioprine results in decreased expression of PSMB9 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:11180 6480464 Benzo(a)pyrene results in decreased expression of PSMB9 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:11180 6480464 Benzo(a)pyrene results in increased expression of PSMB9 mRNA, Benzo(a)pyrene results in increased expression of PSMB9 protein CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene multiple interactions ISO RGD:11180 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PSMB9 mRNA] CTD PMID:22228805 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PSMB9 mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:11180 6480464 Diethylhexyl Phthalate results in decreased expression of PSMB9 mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PSMB9 mRNA CTD PMID:25181051 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PSMB9 gene CTD PMID:28505145 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PSMB9 mRNA CTD PMID:24136188 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PSMB9 mRNA CTD PMID:19167457 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of PSMB9 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:737219 6480464 Calcitriol results in decreased expression of PSMB9 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:11180 6480464 Nanotubes, Carbon analog results in decreased expression of PSMB9 mRNA, Nanotubes, Carbon results in decreased expression of PSMB9 mRNA CTD PMID:25620056 carbon nanotube affects expression ISO RGD:11180 6480464 Nanotubes, Carbon affects the expression of PSMB9 mRNA, Nanotubes, Carbon analog affects the expression of PSMB9 mRNA CTD PMID:25554681 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of PSMB9 mRNA CTD PMID:23125180 chloroprene decreases expression ISO RGD:11180 6480464 Chloroprene results in decreased expression of PSMB9 mRNA CTD PMID:23125180 chromium(6+) affects expression ISO RGD:11180 6480464 chromium hexavalent ion affects the expression of PSMB9 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:11180 6480464 Ciguatoxins affects the expression of PSMB9 mRNA CTD PMID:18353800 cisplatin decreases response to substance ISO RGD:737219 6480464 PSMB9 mRNA results in decreased susceptibility to Cisplatin CTD PMID:23165153 cisplatin multiple interactions ISO RGD:737219 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PSMB9 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:737219 6480464 Cisplatin results in increased expression of PSMB9 mRNA CTD PMID:23165153 more ... clofibrate decreases expression ISO RGD:11180 6480464 Clofibrate results in decreased expression of PSMB9 mRNA CTD PMID:23811191 cobalt dichloride increases expression ISO RGD:11180 6480464 cobaltous chloride results in increased expression of PSMB9 mRNA CTD PMID:21139344 cyclosporin A increases expression ISO RGD:737219 6480464 Cyclosporine results in increased expression of PSMB9 mRNA CTD PMID:20106945 , PMID:22147139 dexamethasone decreases expression ISO RGD:737219 6480464 Dexamethasone results in decreased expression of PSMB9 mRNA CTD PMID:31209803 dexamethasone multiple interactions ISO RGD:737219 6480464 N-(oxo-5 more ... CTD PMID:31209803 dicrotophos decreases expression ISO RGD:737219 6480464 dicrotophos results in decreased expression of PSMB9 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:737219 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB9 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:11180 6480464 Doxorubicin results in decreased expression of PSMB9 mRNA, Doxorubicin results in decreased expression of PSMB9 protein CTD PMID:25896364 doxorubicin increases expression ISO RGD:11180 6480464 Doxorubicin results in increased expression of PSMB9 mRNA CTD PMID:27155237 doxorubicin multiple interactions ISO RGD:11180 6480464 PSMB9 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] more ... CTD PMID:25896364 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PSMB9 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:737219 6480464 entinostat results in increased expression of PSMB9 mRNA CTD PMID:27188386 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PSMB9 mRNA CTD PMID:22061828 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PSMB9 mRNA CTD PMID:24395379 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of PSMB9 mRNA CTD PMID:16452686 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of PSMB9 mRNA CTD PMID:23153324 hydralazine multiple interactions ISO RGD:737219 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB9 mRNA CTD PMID:17183730 lead diacetate decreases expression ISO RGD:11180 6480464 lead acetate results in decreased expression of PSMB9 mRNA CTD PMID:22609695 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of PSMB9 mRNA CTD PMID:24136188 lipopolysaccharide increases expression ISO RGD:11180 6480464 Lipopolysaccharides results in increased expression of PSMB9 mRNA CTD PMID:27339419 lithium atom increases expression EXP 6480464 Lithium results in increased expression of PSMB9 protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of PSMB9 protein CTD PMID:18296634 methotrexate multiple interactions ISO RGD:737219 6480464 [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of PSMB9 mRNA CTD PMID:16817978 methylmercury chloride decreases expression ISO RGD:11180 6480464 methylmercuric chloride results in decreased expression of PSMB9 mRNA CTD PMID:20061341 microcystin RR decreases expression ISO RGD:737219 6480464 microcystin RR results in decreased expression of PSMB9 protein CTD PMID:19111056 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:11180 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PSMB9 mRNA CTD PMID:20061341 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of PSMB9 mRNA CTD PMID:14600272 , PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PSMB9 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:737219 6480464 Nickel results in increased expression of PSMB9 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:737219 6480464 nickel sulfate results in increased expression of PSMB9 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PSMB9 mRNA CTD PMID:24136188 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PSMB9 mRNA CTD PMID:17202759 paracetamol decreases expression ISO RGD:737219 6480464 Acetaminophen results in decreased expression of PSMB9 mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:11180 6480464 Acetaminophen affects the expression of PSMB9 mRNA CTD PMID:17562736 pentachlorophenol increases expression ISO RGD:11180 6480464 Pentachlorophenol results in increased expression of PSMB9 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:11180 6480464 perfluorooctane sulfonic acid results in decreased expression of PSMB9 mRNA, perfluorooctane sulfonic acid results in decreased expression of PSMB9 protein CTD PMID:20936131 , PMID:26178269 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of PSMB9 mRNA CTD PMID:21318169 phenylmercury acetate decreases expression ISO RGD:737219 6480464 Phenylmercuric Acetate results in decreased expression of PSMB9 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737219 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB9 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of PSMB9 mRNA CTD PMID:15215175 pirinixic acid multiple interactions ISO RGD:11180 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PSMB9 mRNA more ... CTD PMID:18467677 more ... pirinixic acid decreases expression ISO RGD:11180 6480464 pirinixic acid results in decreased expression of PSMB9 mRNA CTD PMID:17426115 more ... pirinixic acid increases expression ISO RGD:11180 6480464 pirinixic acid results in increased expression of PSMB9 mRNA CTD PMID:18467677 quercitrin decreases expression ISO RGD:737219 6480464 quercitrin results in decreased expression of PSMB9 mRNA CTD PMID:25193878 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PSMB9 mRNA CTD PMID:28374803 salicylic acid increases expression ISO RGD:737219 6480464 Salicylic Acid results in increased expression of PSMB9 mRNA CTD PMID:23165153 SB 431542 multiple interactions ISO RGD:737219 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMB9 mRNA CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:737219 6480464 Asbestos, Serpentine results in increased expression of PSMB9 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:737219 6480464 Silicon Dioxide analog results in increased expression of PSMB9 mRNA, Silicon Dioxide results in increased expression of PSMB9 mRNA CTD PMID:25351596 , PMID:25895662 silver atom decreases expression ISO RGD:11180 6480464 Silver results in decreased expression of PSMB9 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:11180 6480464 Silver results in decreased expression of PSMB9 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:737219 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of PSMB9 promoter CTD PMID:18448484 sodium arsenite increases expression ISO RGD:11180 6480464 sodium arsenite results in increased expression of PSMB9 mRNA CTD PMID:17350061 Soman increases expression EXP 6480464 Soman results in increased expression of PSMB9 mRNA CTD PMID:19281266 sulfasalazine decreases expression EXP 6480464 Sulfasalazine results in decreased expression of PSMB9 mRNA CTD PMID:17202759 tamibarotene increases expression ISO RGD:737219 6480464 tamibarotene results in increased expression of PSMB9 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:11180 6480464 Tamoxifen affects the expression of PSMB9 mRNA CTD PMID:20937368 tert-butyl hydroperoxide increases expression ISO RGD:11180 6480464 tert-Butylhydroperoxide results in increased expression of PSMB9 mRNA CTD PMID:15003993 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PSMB9 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PSMB9 mRNA CTD PMID:31150632 theophylline affects expression EXP 6480464 Theophylline affects the expression of PSMB9 mRNA CTD PMID:16988215 titanium dioxide increases expression ISO RGD:11180 6480464 titanium dioxide results in increased expression of PSMB9 mRNA CTD PMID:23409001 titanium dioxide decreases expression ISO RGD:11180 6480464 titanium dioxide results in decreased expression of PSMB9 mRNA CTD PMID:27760801 tolfenamic acid increases expression ISO RGD:737219 6480464 tolfenamic acid results in increased expression of PSMB9 mRNA CTD PMID:23165153 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PSMB9 mRNA CTD PMID:19448997 trichostatin A decreases expression ISO RGD:737219 6480464 trichostatin A results in decreased expression of PSMB9 mRNA CTD PMID:24935251 trichostatin A increases expression ISO RGD:737219 6480464 trichostatin A results in increased expression of PSMB9 mRNA CTD PMID:24935251 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of PSMB9 mRNA CTD PMID:21893156 valproic acid multiple interactions ISO RGD:737219 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB9 mRNA CTD PMID:17183730 valproic acid increases expression ISO RGD:737219 6480464 Valproic Acid results in increased expression of PSMB9 mRNA CTD PMID:23527032 more ... valproic acid affects expression ISO RGD:737219 6480464 Valproic Acid affects the expression of PSMB9 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of PSMB9 mRNA CTD PMID:21318169 valproic acid increases expression ISO RGD:11180 6480464 Valproic Acid results in increased expression of PSMB9 mRNA CTD PMID:21427059 vancomycin decreases expression ISO RGD:11180 6480464 Vancomycin results in decreased expression of PSMB9 mRNA CTD PMID:18930951 vitamin E increases expression ISO RGD:737219 6480464 Vitamin E results in increased expression of PSMB9 mRNA CTD PMID:19244175
Gene-Chemical Interaction Annotations
